UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON,Washington, D.C. 20549

SCHEDULE 14A

(RuleRULE 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities

Securities Exchange Act of 1934

(Amendment No.   )

Filed by the Registrant  [ X ]

xFiled by a Party other than the Registrant  [    ]¨

Check the appropriate box:

[    ]Preliminary

Landauer, Inc.

(Name of Registrant as Specified in Its Charter)

(Name of Person(s) Filing Proxy Statement,

[ X ]Definitive Proxy Statement

[     ]Definitive Additional Materials

[     ]Soliciting Material Pursuant to §240.14a-12

[     ]Confidential, for Use of if other than the Commission Only (as permitted by Rule 14a-6(e)(2))Registrant)

Payment of Filing Fee (Check the appropriate box):

[ X ]   No fee required.

[    ]   Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

[     ]   Fee paid previously with preliminary materials.

[    ]   Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing.

LANDAUER, INC.

2 SCIENCE ROAD, GLENWOOD, ILLINOIS 60425-1586

TELEPHONE (708) 755-7000

January 12, 2016

Dear Landauer Stockholder:

On behalf of Landauer, Inc. (the “Company”), we are pleased to invite the stockholders of the Company to attend the Annual Meeting of Stockholders of Landauer, Inc., to be held on February 18, 2016, at 10:00 a.m., local time, at 8755 West Higgins Road, Chicago, Illinois.

Fiscal 2015 was a challenging year for the Company. Under David E. Meador’s leadership as Chairman of the Audit Committee, we worked aggressively to remediate all material control weaknesses identified in the Company’s 2014 Annual Report on Form 10-K. In addition, the Company replaced its financial leadership team by appointing a new Chief Financial Officer and a new Chief Accounting Officer in April 2015. More detail about the Company’s remediation efforts can be found in the Audit Committee Report in the Proxy Statement that this letter accompanies.

Under the leadership of Michael T. Leatherman and Michael P. Kaminski, we maintained focus on critical strategic initiatives and developed our long-term strategy during fiscal 2015. Our core strategy focuses on recurring revenue initiatives of higher margin products and services. We continued to make progress on our growth initiatives, including our next generation digital dosimeter platform, Verifii™ and are well positioned to meet the emerging needs for a broader radiation management solution. We are seeing strong demand for our solutions following the Joint Commission’s new Diagnostic Imaging requirements that became effective for hospitals and ambulatory care centers on July 1, 2015 and we believe this trend will continue to drive further growth opportunities and long-term value for stockholders.

To prepare the organization to fully execute our strategy, the Company made additional changes in its leadership. Effective October 1, 2015, Michael T. Leatherman stepped down as the Company’s President and Chief Executive Officer and was appointed to the new position of Executive Chairman of the Board. At the same time, Robert J. Cronin was appointed to the new position of Lead Director of the Board of Directors. With the resignation of Mr. Leatherman as President and Chief Executive Officer, the Board of Directors appointed Michael P. Kaminski as the Company’s new President and Chief Executive Officer. In addition, Jeffrey A. Bailey was appointed to the Board in April 2015. Mr. Bailey’s experience in the pharmaceutical industry and knowledge of the opportunities created by the new requirements of the Joint Commission will be beneficial as we execute our long-term strategy. More detail about all of these changes can be found in the Proxy Statement that this letter accompanies.

We have continued to improve corporate governance at the Company during fiscal 2015. We declassified the Board of Directors and adopted majority voting for directors in uncontested elections at the 2015 Annual Meeting. In addition, we modified our compensation design for long-term incentive awards by adding a Return on Invested Capital metric that further aligns management’s incentives with stockholder interests.

Your vote at the Annual Meeting is very important. Whether or not you plan to attend the meeting, we urge you to vote either via the Internet, by telephone or by signing and returning a proxy card. Please vote as soon as possible so that your shares will be represented.

Thank you for your continued support of Landauer.

Sincerely,

Michael T. Leatherman

Executive Chairman of the Board of Directors

Michael P. Kaminski

President and Chief Executive Officer

TABLE OF CONTENTS

LANDAUER, INC.

2 SCIENCE ROAD,

GLENWOOD, ILLINOIS 60425-1586

TELEPHONE (708) 755-7000

NOTICE OF ANNUAL MEETING OF STOCKHOLDERS

Notice is hereby given that the Annual Meeting of Stockholders of Landauer, Inc. will be held at 8755 West Higgins Road, Chicago, Illinois, at 10:00 a.m., local time, on Thursday, February 20, 201418, 2016 for the following purposes:

1.To re-elect the three directors identified in this Proxy Statement to hold office for an additional term of three years each.

4.To transact such other business as may properly come before the meeting.

Only stockholders of record at the close of business on January 6, 2014December 31, 2015 are entitled to notice of and to vote at the meeting.

IT IS IMPORTANT THAT YOUR SHARES BE REPRESENTED AT THE MEETING. WHETHER OR NOT YOU EXPECT TO ATTEND THE MEETING, THE COMPANY STRONGLY URGES YOU TO VOTE VIA THE INTERNET, TELEPHONE, OR REQUESTCOMPLETING AND RETURNING A PAPER PROXY CARD TO COMPLETE AND RETURN BY MAIL. IF YOU ATTEND THE MEETING AND VOTE IN PERSON, YOUR PROXY WILL NOT BE USED.

DANIEL J. FUJII

Vice President, Chief Financial Officer and Secretary

January 12, 2016

Important Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to Be Held on February 18, 2016.Our Proxy Statement and the Landauer, Inc. 2015 Annual Report on Form 10-K are available online atwww.proxyvote.com or at our investor relations website.

PROXY STATEMENT SUMMARY

ANNUAL MEETING INFORMATION

We are providing this Proxy Statement to you in connection with the solicitation of proxies by the Board of Directors of Landauer, Inc. for the Annual Meeting of Stockholders and for any adjournment or postponement of the meeting (the “Annual Meeting”). We expect to begin mailing our proxy materials on or about January 12, 2016.

Time and Place: We are holding the Annual Meeting at 10:00 a.m. Central Standard Time on Thursday, February 18, 2016, at Landauer Inc., 8755 West Higgins Road, Chicago, Illinois.

Attendance Requirements: You may attend the Annual Meeting and vote in person even if you have returned a proxy in writing, by telephone or through the Internet.

Street-Name Holders: If you hold shares in a bank or brokerage account (known as shares held in “street name”), you must obtain a valid “legal proxy,” executed in your favor from the holder of record, if you wish to vote these shares at the meeting.

MICHAEL K. BURKEMatters for Stockholder Voting

Senior Vice President and Chief Financial OfficerAt this year’s Annual Meeting, we are asking our stockholders to vote on the following matters:

		1

January 7, 2014

PROXY STATEMENT

APPROXIMATE DATE OF NOTICE: January 7, 2014JANUARY 12, 2016

INFORMATION CONCERNING THE PROXY SOLICITATION

This proxy is solicited by the Board of Directors of Landauer, Inc. (the “Company”, “we”, “our”, “us” or “Landauer”) on behalf of the Company for use at its Annual Meeting of Stockholders (the “Annual Meeting”) to be held on Thursday, February 20, 201418, 2016 at 8755 West Higgins Road, Chicago, Illinois, at 10:00 a.m., local time, or any adjournments or postponements thereof. You may revoke your proxy at any time prior to it being voted by giving written notice to the Corporate Secretary of Landauer, by submission of a later dated proxy or by voting in person at the meeting. The costs of solicitation will be paid by Landauer. Solicitations may be made by the officers and employees of Landauer personally or by telephone.

In accordance with rules and regulations adopted by the U.S. Securities and Exchange Commission (the “SEC”), instead of mailing a printed copy of its proxy materials to each stockholder of record, Landauer furnishes proxy materials on the Internet.  You will not receive a printed copy of the proxy materials, unless specifically requested.  This process is designed to expedite stockholders’ receipt of proxy materials, lower the cost of the Annual Meeting and help conserve natural resources.

On or around January 7, 2014,12, 2016, the Company mailedwill mail to its stockholders, other than those who previously requested electronic or paper delivery, a Notice Regarding the Availability of Proxy Materials (the “Notice”), which contains instructions as to how you may access and review all of the Company’s proxy materials including the Proxy Statement and 20132015 Annual Report on Form 10-K, on10-K. The proxy card included with the Internet.  The Notice alsomaterials instructs you as to how you may vote your proxy on the Internet or by telephone.  However, if you would prefer to receive printed proxy materials, please follow

The rules of the instructions for requesting such materials as contained in the Notice.

The SEC’s rulesU.S. Securities and Exchange Commission (the “SEC”) permit the Company to deliver a single Notice or set of Annual Meeting materials to one address shared by two or more of the Company’s stockholders. This delivery method is referred to as “householding” and can result in significant cost savings. To take advantage of this opportunity, Landauer has delivered only one Notice or set of Annual Meeting materials to multiple stockholders who share an address, unless the Company received contrary instructions from the impacted stockholders prior to the mailing date. Landauer agrees to deliver promptly, upon written or oral request, a separate copy of the Notice or Annual Meeting materials, as requested, to any stockholder at the shared address to which a single copy of those documents was delivered. If you prefer to receive separate copies of the Notice or Annual Meeting materials, contact Broadridge, Householding Department, at 51 Mercedes Way, Edgewood, NY 11717, or by telephone at 800-542-1061. If you are currently a stockholder sharing an address with another stockholder and wish to receive only one copy of future Notices or Annual Meeting materials for your household, please contact Broadridge at the above phone number or address.

On December 31, 2013,2015, Landauer had outstanding 9,538,0229,581,743 shares of Common Stock, which is its only class of voting stock, held of record by 272232 holders. Only stockholders of record at the close of business on January 6, 2014December 31, 2015 will be entitled to receive notice of and to vote at the meeting and any adjournments or postponements thereof. With respect to all matters that will come before the meeting, each stockholder may cast one vote for each share registered in his or her name on the record date.

The shares represented by every proxy received will be voted, and where a choice has been specified, the shares will be voted in accordance with the specification so made. If no choice has been specified on the proxy that has been signed and returned, the shares will be voted FOR the election of the nominees as directors, and, FOR the ratification of the appointment of PricewaterhouseCoopersBDO USA, LLP (“BDO”), as the independent registered public accounting firm.  firm, FOR the approval of our compensation for named executive officers and FOR the approval of the 2016 Landauer, Inc. Incentive Compensation Plan.

The proxy also gives authority to the proxies to vote the shares at their discretion on any other matter presented at the meeting. If a proxy indicates that all or a portion of the shares represented by such proxy are not being voted with respect to a particular proposal, such non-voted shares will not be considered present and entitled to vote on such proposal, although such shares may be considered present and entitled to vote on other proposals and will count for the purpose of determining the presence of a quorum. An abstention with respect to a proposal has the effect of a vote against a proposal.  “Brokerproposal, other than with respect to the proposal to elect directors. Abstentions will have no effect on the proposal to elect directors.

“Broker non-votes” are counted toward the quorum requirement but they do not affect the determination of whether a matter is approved. A broker non-vote occurs when a broker cannot vote on a matter because the broker has not received instructions from the beneficial owner and lacks discretionary voting authority with respect to that matter. It is expected that brokers will lack discretionary voting authority with respect to the election of nominees as directors, the approval of our compensation program for named executive officers and the proposal relating to the approval of the performance measures under the Company’s incentive

compensation plan,2016 Landauer, Inc. Incentive Compensation Plan, but will not lack discretionary voting authority with respect to the proposal regarding ratification of the independent registered public accounting firm at the Annual Meeting.

2

BENEFICIAL OWNERSHIP OF COMMON STOCK

The following table provides information as of November 30, 2013December 31, 2015 concerning beneficial ownership of Common Stock by each person known by Landauer to own beneficially more than 5% of the outstanding shares of Common Stock, each director, each director nominee, each executive officer named under the caption “Executive Compensation” and all directors and executive officers as a group. Unless otherwise noted, the listed persons have sole voting and dispositive powers with respect to shares held in their names, subject to community property laws, if applicable. Percentage ownership is based on an aggregate 9,581,743 shares of Common Stock outstanding on December 31, 2015. Unless otherwise noted, the address of each beneficial owner is c/o Landauer, Inc., 2 Science Road, Glenwood, Illinois60425-1586.

*Less than one percent.

(1)As reported in a statement on Schedule 13G filed with the Securities and Exchange Commission on February 28, 2013.  This stockholder’s address is 745 Fifth Avenue, New York, NY 10151.

(2)As reported in a statement on Schedule 13G filed with the Securities and Exchange Commission on February 14, 2013.  Includes 555,500 shares owned by the T. Rowe Price Small Cap Value Fund, Inc.  T. Rowe Price Associates expressly disclaims beneficial ownership of such securities.  This stockholder’s address is 100 East Pratt Street, Baltimore, MD 21202.

(3)As reported in a statement on Schedule 13G filed with the Securities and Exchange Commission on February 4, 2013.  This stockholder’s address is 40 East 52nd Street, New York, NY 10022.

(4)As reported in a statement on Schedule 13G filed with the Securities and Exchange Commission on January 29, 2013.  Includes 12,768 shares for which Vanguard Fiduciary Trust Company (“VFTC”), a wholly-owned subsidiary of The Vanguard Group, Inc., is the beneficial owner, as a result of serving as investment manager of collective trust accounts.  VFTC directs the voting of these shares.  This stockholder’s address is 100 Vanguard Boulevard, Malvern, PA 19355.

(5)Includes 50,000 shares subject to options exercisable within 60 days after November 30, 2013.

(6)Includes 6,000 shares subject to options exercisable within 60 days after November 30, 2013.

(7)Includes 1,500 shares subject to options exercisable within 60 days after November 30, 2013.

(8)Includes 57,500 shares subject to options exercisable within 60 days after November 30, 2013.

Section 16(a) Beneficial Ownership Reporting Compliance

		3

SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

Section 16(a) of the Securities Exchange Act of 1934 requires Landauer’s officers and directors and persons who beneficially own more than ten percent of Landauer’s Common Stock (“Reporting Persons”) to file reports of beneficial ownership and changes in such ownership with the SEC. Reporting Persons are required by SEC regulation to furnish Landauer with copies of all Section 16(a) reports they file and Landauer is required to post such reports on its website,http://www.landauer.com.

Based solely on a review of the Forms 3, 4 and 5 filings received from, or filed by Landauer on behalf of, Reporting Persons since the beginning of fiscal year 2013, Landauer2015, the Company believes that all Section 16(a) filing requirements were met during fiscal year 2013.2015.

4

ELECTION OF DIRECTORS

Members ofIn December 2014, Landauer’s Board of Directors are divided into three classes serving staggered three-year terms,approved an amendment to the Company’s by-laws to change the election of directors to the Board in uncontested elections from plurality to majority voting. Only directors that receive a majority of the votes cast “FOR” their election will be elected. Abstentions and broker non-votes with a totalrespect to the election of nine directors authorized.  No Director will standnot affect the outcome of the election of directors. In the event that an incumbent director is not re-elected, the Company’sGovernance and Nominating Standardsrequire that director to tender his or her resignation for consideration by the Governance and Nominating Committee. The Governance and Nominating Committee will recommend to the Board of Directors whether to accept or reject the resignation, or whether other action should be taken. The Board of Directors will act on the resignation and publicly disclose its decision regarding the resignation and the rationale behind the decision within 90 days following certification of the election after their 72nd birthday.results.

At the Annual Meeting of Stockholders of the Company held on March 6, 2015, the Company’s stockholders approved an amendment to the Certificate of Incorporation of the Company to declassify the Board of Directors. The terms of threefour of the seveneight current directors expire at the Annual Meeting. The threeThese directors, Robert J. Cronin, William G. DempseyJeffrey A. Bailey, Michael P. Kaminski, Michael T. Leatherman and WilliamDavid E. Saxelby,Meador, are Landauer’s nominees for re-election to a three-year term.one-year term each.

Effective April 15, 2015, the Board of Directors appointed Jeffrey A. Bailey as an independent director of the Board, increasing the size of the Board to seven individuals. Mr. Bailey was recommended as a nominee by an outside search firm, which had been retained by the Governance and Nominating Committee to assist it in identifying possible director candidates. On August 25, 2015, the Board of Directors appointed Michael P. Kaminski as the Company’s President and Chief Executive Officer, and as a member of the Board of Directors, with both appointments effective on October 1, 2015. In connection with the appointment of Mr. Kaminski as a member of the Board of Directors, the Board approved the increase in the size of the Board from seven to eight effective October 1, 2015.

Landauer’s by-laws provide that nominations for directorships by stockholders only may be made pursuant to written notice received at the Company’s principal office not less than 90, and not more than 120, calendar days prior to the first anniversary of the preceding year’s annual meeting. No such nominations were received for the meeting as of November 23, 2013.this year’s deadline.

Proxies may not be voted for a greater number of persons than the threefour named nominees.  Directors are elected by a plurality of the votes present in person or represented by proxy at the meeting and entitled to vote on the election of directors.  Thus, assuming a quorum is present, the three persons receiving the greatest number of votes will be elected to serve as directors.  Accordingly, withholding authority to vote for a director and broker non-votes with respect to the election of directors will not affect the outcome of the election of directors. If a nominee should become unavailable for election, the persons voting the accompanying proxy may at their discretion vote for a substitute.

The Board of Directors recommends a vote FOR the re-election of Mr. Cronin, Mr. Dempsey and Mr. Saxelby as directors of Landauer.

Certain information as to the threefour nominees for re-election at the Annual Meeting and each other person whose term of office as a director will continue after the meeting is set forth below. Certain individual qualifications, experiences and skills of the directors that contribute to the Board of Directors’ effectiveness as a whole are also described below.  The nominees for re-election at the meeting are Mr. Cronin, Mr. Dempsey and Mr. Saxelby.

		5

DIRECTOR NOMINEES:

Jeffrey A. Bailey, age 53, has been a director since April 2015. Since January 2013 through September 2015, Mr. Bailey served as President and Chief Executive Officer and a Director of Lantheus Medical Imaging, Inc., a global leader in providing diagnostic imaging agents, primarily used for the diagnosis of cardiovascular diseases. From August 2011 to December 2012, Mr. Bailey was Chief Operating Officer of Fougera Pharmaceuticals (formerly Nycomed US), a company that develops, manufactures and markets specialty topical and dermatology medicines. From August 2010 to July 2011, he was Chief Commercial Officer of King-Pfizer Pharmaceuticals, a diversified specialty pharmaceutical discovery and clinical development company, and from 2008 to 2010, Mr. Bailey was President and General Manager of Novartis NorthWest Operating Unit. From 1984 to 2006, Mr. Bailey held various executive, commercial and manufacturing roles within the Johnson & Johnson family of companies. Mr. Bailey serves on the Audit and Compensation Committees.

Director Nominees:

6

---

Election of Directors			PROXY STATEMENT
Robert J. Cronin (3)
Since 2001, Managing Partner, The Open Approach LLC, a provider of consulting services and investment banking to the printing industry.  From November 2005 to April 2006, Chairman and Chief Executive Officer, York Label, Inc., a supplier of pressure-sensitive labels and related systems.  Until January 2000, Chairman of the Board and Chief Executive Officer of Wallace Computer Services; previously President, Chief Executive Officer and Director; now retired.  Wallace Computer Services is a provider of information management products, services and solutions.
Qualifications:  Mr. Cronin’s experience as a Chairman and Chief Executive Officer at two companies provides valuable insight for the Company as to the issues and opportunities facing the Company, as well as experience in strategic planning and leadership of complex organizations.  He also has considerable corporate governance experience through years of service in leadership positions with various public companies.
Current Directorships: Director of various privately held corporations.
Former Directorships: None
Age: 69
Director Since: 1997
Expiration of Current Term: 2014

Directors Continuing in Office:

MemberMichael T. Leatherman, age 62, has been a director since 2008. Effective October 2015, Mr. Leatherman was appointed to the role of Executive Chairman of the (1) Audit Committee, (2) Compensation Committee, (3)Board of Directors of the Company. From December 2014 through September 2015, Mr. Leatherman served as President and Chief Executive Officer of Landauer, Inc. From September 2014 through December 2014, Mr. Leatherman was our Interim President and Chief Executive Officer, and from September 2011 through December 2011, he was Interim Chief Financial Officer of the Company. Since 2000, Mr. Leatherman has served as an Independent Consultant primarily to the information technology industry. From 1990 to 2000, Mr. Leatherman held various senior leadership positions with Wallace Computer Services including Executive Vice President, Chief Information Officer and Chief Financial Officer from 1998 to 2000. From 1984 to 1990, Mr. Leatherman was Chief Executive Officer of FSC Paper Corporation, a subsidiary of Smorgon Consolidated Industries. Mr. Leatherman is a Certified Public Accountant.

Qualifications: Mr. Leatherman’s extensive experience as a senior executive with a wealth of information technology knowledge provides expertise in information systems strategy and project implementation, as well as expertise in general operational and strategic leadership. In addition, he brings financial acumen to Board discussions by virtue of his background as a Chief Financial Officer.

Current Directorships: None

Former Directorships: From 2006 to 2009, Director of Nashua Corporation, which was acquired by Cenveo, Inc., a NYSE listed company; and Director of a non-profit organization providing continuous care retirement services.

Expiration of Current Term: 2016

David E. Meador, age 58, has been a director since 2008. Since 2014, Mr. Meador has served as Vice Chairman and Chief Administrative Officer, DTE Energy. Since 2001, Mr. Meador served as Executive Vice President and Chief Financial Officer, DTE Energy. From 1997 to 2001, Mr. Meador was Vice President and Controller, DTE Energy. DTE Energy provides safe, reliable electric and natural gas services to Michigan businesses and homes and has energy related businesses and services nationwide. From 1983 to 1997, Mr. Meador served in a variety of financial and accounting positions at Chrysler Corporation. Mr. Meador began his professional career with Coopers and Lybrand and is a Certified Public Accountant. Mr. Meador serves on the Governance and Nominating Committee and is Chairman of the Audit Committee.

Qualifications: Mr. Meador’s experience as a senior executive with an energy company provides substantial experience in the Nuclear Power industry. Mr. Meador’s role as an active executive provides a perspective of a leader familiar with many facets of an enterprise facing the same set of current external economic and governance issues. As Chairman of the Audit Committee, he has dedicated significant time and effort in overseeing improvements to the Company’s controlenvironment and risk assessment and to remediate the identified material weaknesses. In addition, he brings financial acumen to Board discussions by virtue of his background as a Chief Financial Officer.

Current Directorships: None

Former Directorships: None

Expiration of Current Term: 2016

		7

DIRECTORS CONTINUING IN OFFICE:

Robert J. Cronin, age 71, has been a director since 1997. Since 2001, Mr. Cronin has served as Managing Partner, The Open Approach LLC, a provider of consulting services and investment banking to the printing industry. From November 2005 to April 2006, Mr. Cronin was Chairman and Chief Executive Officer, York Label, Inc., a supplier of pressure-sensitive labels and related systems. Until January 2000, Mr. Cronin was Chairman of the Board and Chief Executive Officer of Wallace Computer Services; previously President, Chief Executive Officer and Director; now retired. Wallace Computer Services is a provider of information management products, services and solutions. Mr. Cronin serves on the Audit and Governance and Nominating Committees and is the Lead Director of the Board of Directors.

Qualifications: Mr. Cronin’s experience as a Chairman and Chief Executive Officer at two companies provides valuable insight for the Company as to the issues and opportunities facing the Company, as well as experience in strategic planning and leadership of complex organizations. He also has considerable corporate governance experience through years of service in leadership positions with various public companies.

Current Directorships: Director of various privately-held corporations.

Former Directorships: None

Expiration of Current Term: 2017

William G. Dempsey, age 64, has been a director since 2008. Since 2007, Mr. Dempsey retired and has been serving as Director of various public and private companies. From 1982 to 2007, Mr. Dempsey held various senior leadership positions with Abbott Laboratories including Executive Vice President, Global Pharmaceuticals from 2006 to 2007. Abbott Laboratories is a global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health. From 1977 to 1982, Mr. Dempsey held various positions with Sciaky Bros., a manufacturer of high-tech electron beam, laser welding and heat treating systems. Mr. Dempsey serves on the Governance and Nominating Committee and is Chairman of the Compensation Committee.

Qualifications: Mr. Dempsey’s extensive experience as a senior executive with a global pharmaceutical company provides a wealth of health care experience in global healthcare markets including pharmaceuticals, nutrition and medical devices. Mr. Dempsey’s leadership experience provides expertise in strategy, marketing, international operations, manufacturing and managing research and development organizations.

Current Directorships: Director of Hill-Rom Holdings, Inc., a NYSE listed company. Mr. Dempsey also serves on the Salvation Army Advisory Board in Chicago and is a member of the Board of Trustees of the Guadalupe Center in Immokalee, Florida.

Former Directorships: Director of Hospira, Inc., a NYSE listed company; Director of MDS Inc.; Director of Nordion, Inc.; and Director of TYRX, Inc.

Expiration of Current Term: 2017

8

Stephen C. Mitchell, age 72, has been a director since 2005. Since 2001, Mr. Mitchell has served as President, Knight Group LLC, a privately-held firm providing services for the start-up and management of new ventures. Since 1995, Mr. Mitchell was Vice Chairman and Director, Knight Facilities Management, a company providing outsourcing of facilities management services for industrial and commercial clients worldwide. Until 2001, Mr. Mitchell was President, Chief Operating Officer and Director, Lester B. Knight & Associates, Inc., a company involved in the planning, design and construction of advanced technology research and development and manufacturing facilities. Mr. Mitchell serves on the Compensation Committee and is Chairman of the Governance and Nominating Committee.

Qualifications: Mr. Mitchell’s extensive leadership experience in various companies of diverse industry and size provides experience in operational and strategic leadership. He also has considerable corporate governance experience through years of service on other public company boards.

Current Directorships: None

Former Directorships: Director of Apogee Enterprises, Inc., a NASDAQ listed company.

Expiration of Current Term: 2018

Thomas M. White, age 58, has been a director since 2004. In January 2015, Mr. White became the Executive Chairman of Cardinal Logistics Holdings, LLC, which provides dedicated transportation and logistics services. From 2007 to 2014, Mr. White served as Operating Partner for Apollo Management L.P., a private equity firm. During 2013 and 2014, Mr. White served as Interim Chief Operating Officer of CEVA Logistics, an Apollo owned entity in the Netherlands, which provides contract logistics and freight forwarding services. During 2011 and 2012, he served as Chief Financial Officer of Constellium, an Apollo owned entity in France, which produces aluminum products. During 2009 and 2010, Mr. White served as Chief Financial Officer of SkyLink Aviation, Inc., an Apollo owned entity in Canada, which provides air charter logistics services. From 2002 to 2007, Mr. White served as Chief Financial Officer of Hub Group, Inc., a NASDAQ listed company which provides logistics services. Prior to joining Hub Group, Mr. White was an audit partner with Arthur Andersen, which he joined in 1979. Mr. White is a Certified Public Accountant. Mr. White serves on the Audit and Compensation Committees.

Qualifications: Mr. White’s extensive experience as a senior executive of global companies provides in-depth knowledge in global operations, finance, international business and strategic planning. In addition, he brings financial acumen to Board discussions by virtue of his background as a Chief Financial Officer.

Current Directorships: Director of CEVA Group, PLC and Cardinal Logistics Holdings, LLC.

Former Directorships: Director of Quality Distribution, Inc., a NASDAQ listed company; Director of EVERTEC, Inc., a NASDAQ listed company; Director of FTD, Inc., a NYSE listed company; and SkyLink Aviation, Inc.

Expiration of Current Term: 2018

There are no family relationships between any director or executive officer and any other director or executive officer of the Company.

		9

EXECUTIVE OFFICERS

The executive officers of the Company are elected by its Board of Directors. Each serves until a successor is elected and qualified, or until the officer’s resignation or removal.

William E. Saxelby’s biographyMr. Kaminski’s and Mr. Leatherman’s biographies can be found in the Director Nominees“Director Nominees” section ofunder the Election of Directors section.Directors.

Position: Vice President, Chief Financial Officer and Secretary

Age: 41

Mr. Fujii has served as the Company’s Vice President, Chief Financial Officer and Secretary, as well as its principal financial officer, since April 2015. Prior to this appointment, Mr. Fujii served as Vice President, Corporate Controller and Chief Accounting Officer of the Company since April 2014. From January 2012 to March 2014, he was corporate controller of Actient Pharmaceuticals, LLC, a private specialty pharmaceuticals company that was acquired by Auxilium Pharmaceuticals, Inc. From October 2007 to January 2012, he was director of finance and controller for Nanosphere, Inc., a manufacturer of medical diagnostic equipment. Mr. Fujii’s experience includes financial leadership positions at several other publicly held organizations, including Richardson Electronics, Ltd., a provider of engineered solutions and distributor of electronic components to the electron device marketplace, and he began his career at PricewaterhouseCoopers LLP. He is a certified public accountant and earned a Bachelor of Science in accounting from the University of Illinois.

Position: Senior Vice President, Strategic Marketing and Product Development

Age: 57

Mr. Kennedy has served as Senior Vice President, Strategic Marketing and Product Development since April 2015. He was President of Landauer Medical Physics, a subsidiary of Landauer Inc., and Vice President Global Marketing for Landauer Inc. from August 2011 through April 2015. Mr. Kennedy has over 25 years of healthcare technology innovation and commercial leadership experience in both Fortune 500 and smaller private healthcare companies. Prior to joining Landauer, he held executive positions in strategic marketing, operations, product development, and general management at Baxter Healthcare, GE, and private healthcare companies. In these roles, he led significant medical device innovations and business transformations in dialysis, blood component therapy, inhaled drug delivery, and diagnostic imaging lifecycle management services. Mr. Kennedy earned a Bachelor of Science in chemical engineering from the University of Washington and an MBA from J.L. Kellogg Graduate School of Management at Northwestern University.

Position: Senior Vice President, Administration and Chief Information Officer

Age: 48

Mr. King has served as Senior Vice President, Administration and Chief Information Officer since April 2015. He was Vice President and Chief Information Officer of the Company since April 2009. Mr. King has over 20 years of experience in both Fortune 500 and smaller private manufacturing and industrial companies. Prior to Landauer, Mr. King held several Operations leadership roles, including Senior VP and Chief Information Officer, Senior VP of Sales and Marketing, Corporate Vice President of Operations, Director of Supply Chain Management, and Program Office Director. Mr. King earned a dual Masters Degree (MBA, MEM) from the J.L. Kellogg Graduate School of Management at Northwestern University, where he graduated with concentrations in Management & Strategy, Information Technology and Manufacturing Management. He also earned his Bachelor of Arts at Northwestern University.

10

6

7

8

9

10

11

12

13